Table 1.
Patient, tumor, and treatment characteristics of HER2-positive patients with or without indication trastuzumab treatment according to 2005 Dutch guidelines
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.